Rights and permissions
About this article
Cite this article
Paclitaxel-eluting stent cost effective in high-risk patients in Sweden. Pharmacoecon. Outcomes News 500, 8 (2006). https://doi.org/10.2165/00151234-200605000-00021
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605000-00021